跳至主要内容
临床试验/NCT00805597
NCT00805597终止3 期

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Chinese Academy of Medical Sciences2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
40
试验地点
2
主要终点
overall survival

研究概览

简要总结

The purpose of this study is to evaluate postmastectomy radiotherapy in breast cancer patients with one to three positive nodes.

详细描述

Eligible breast cancer patients with mastectomy and axillary dissection are randomized into 2 groups:radiotherapy of 50 Gy in 25 fractions within 5 weeks to ipsilateral chest wall and supraclavicular nodal region,and no radiotherapy.

During and after radiotherapy, the patients are followed and the efficacy and toxicities of radiotherapy are evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Ipsilateral histologically confirmed invasive breast cancer
  • Undergone total mastectomy and axillary dissection
  • T1-2 and one to three axillary lymph nodes positive
  • A minimum of 10 axillary nodes dissected
  • Fit for chemotherapy(if indicated),endocrine therapy(if indicated)and postoperative irradiation
  • Written,informed consent

排除标准

  • Patients who undergone previous irradiation to the ipsilateral chest wall and supraclavicular region
  • Previous or concurrent malignant other than non-melanomatous skin cancer
  • Unable or unwilling to give informed consent

结局指标

主要结局

overall survival

时间窗: 10 years

次要结局

  • loco-regional recurrence(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shu lian Wang

M.D.

Chinese Academy of Medical Sciences

研究点 (2)

Loading locations...

相似试验